IRIS
CACCIOLA, Emma
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.002
AS - Asia 7.282
EU - Europa 6.618
SA - Sud America 1.296
AF - Africa 474
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 10
Totale 29.693
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.380
SG - Singapore 4.076
RU - Federazione Russa 1.834
CN - Cina 1.821
IE - Irlanda 1.328
UA - Ucraina 1.264
BR - Brasile 1.069
IT - Italia 801
VN - Vietnam 524
CA - Canada 515
FR - Francia 449
KR - Corea 211
DE - Germania 202
NG - Nigeria 187
GB - Regno Unito 173
IN - India 159
SE - Svezia 142
CI - Costa d'Avorio 107
AR - Argentina 75
NL - Olanda 71
BD - Bangladesh 69
PL - Polonia 67
CH - Svizzera 57
MX - Messico 56
ZA - Sudafrica 52
TR - Turchia 47
UZ - Uzbekistan 47
IQ - Iraq 44
EC - Ecuador 41
FI - Finlandia 41
JP - Giappone 39
HK - Hong Kong 36
ES - Italia 35
KE - Kenya 29
ID - Indonesia 28
PK - Pakistan 28
CO - Colombia 26
VE - Venezuela 26
AT - Austria 21
SA - Arabia Saudita 21
EG - Egitto 19
GR - Grecia 19
MA - Marocco 18
LB - Libano 17
SN - Senegal 17
CZ - Repubblica Ceca 16
BE - Belgio 14
BJ - Benin 14
PY - Paraguay 14
CL - Cile 13
LT - Lituania 13
PE - Perù 13
RO - Romania 13
TW - Taiwan 12
BG - Bulgaria 11
PH - Filippine 11
IL - Israele 9
JO - Giordania 9
MY - Malesia 9
PT - Portogallo 9
UY - Uruguay 9
BY - Bielorussia 8
EU - Europa 8
IR - Iran 8
JM - Giamaica 8
TN - Tunisia 8
TT - Trinidad e Tobago 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
BO - Bolivia 7
DZ - Algeria 7
NP - Nepal 7
DO - Repubblica Dominicana 6
KW - Kuwait 6
KZ - Kazakistan 6
LY - Libia 6
AZ - Azerbaigian 5
CR - Costa Rica 5
ET - Etiopia 5
NI - Nicaragua 5
PS - Palestinian Territory 5
HN - Honduras 4
HR - Croazia 4
OM - Oman 4
SI - Slovenia 4
AL - Albania 3
AM - Armenia 3
KG - Kirghizistan 3
LV - Lettonia 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
QA - Qatar 3
RS - Serbia 3
SY - Repubblica araba siriana 3
BB - Barbados 2
BH - Bahrain 2
GY - Guiana 2
HU - Ungheria 2
KH - Cambogia 2
Totale 29.665
Salva come PNG Salva come JPEG
Città #
Dallas 2.536
Singapore 2.236
Dublin 1.324
Jacksonville 1.219
Santa Clara 1.189
Ashburn 1.072
San Jose 1.034
Chandler 954
Moscow 683
Boardman 526
Nanjing 422
Andover 367
Cambridge 360
Toronto 358
Lawrence 353
Lauterbourg 348
Hefei 247
San Mateo 229
Seoul 210
Des Moines 202
Chicago 198
Los Angeles 195
Beijing 166
Ho Chi Minh City 156
Catania 146
Wilmington 145
Nanchang 123
Hanoi 113
Abidjan 107
Lagos 103
São Paulo 100
Hebei 98
New York 95
Shenyang 95
Saint Petersburg 84
Council Bluffs 79
Buffalo 77
Grafing 77
Ottawa 77
Jiaxing 75
Civitanova Marche 73
Changsha 68
Abuja 66
Tianjin 66
Warsaw 53
Montreal 44
Rio de Janeiro 39
Milan 35
Bari 34
Orem 34
Phoenix 34
Tokyo 33
Seattle 32
Amsterdam 31
Hong Kong 31
Dong Ket 30
Johannesburg 30
Brooklyn 29
Denver 29
Boston 28
Bremen 28
Da Nang 27
Palermo 27
Washington 27
Houston 25
Kunming 25
Norwalk 25
Poplar 25
Pune 25
Redondo Beach 25
San Francisco 25
Munich 24
Quito 24
Atlanta 23
Stockholm 23
Tashkent 23
Den Haag 22
Chennai 21
Helsinki 21
Belo Horizonte 20
London 20
Mumbai 20
Curitiba 19
Hangzhou 19
Liberty Lake 19
Manchester 19
Ann Arbor 18
Baghdad 18
Brasília 18
Haiphong 18
Port Harcourt 18
Dakar 17
Mexico City 16
Rome 15
Augusta 14
Brussels 14
Cotonou 14
Jinan 14
Ningbo 14
Porto Alegre 14
Totale 19.820
Salva come PNG Salva come JPEG
Nome #
Elevated fibronectin plasma levels in diabetes mellitus are expression of increased synthesis and release by vascular endothe- lium. 464
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1) 220
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 211
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 203
Contributo delle piastrine reticolate alla generazione del fattore tessutale e del fattore di crescita trasformante-beta nella mielofibrosi primaria. Reticulated platelets contribution to tissue factor and transforming growth factor-beta generation in primary myelofibrosis. 187
B-linfociti CALLA (CD10) positivi nella leucemia linfatica cronica. 181
Thrombotic risk stratification in patients with prefibrotic myelofibrosis 167
Activation of coaugulation and fibrinolysis in laparoscopic surgery 167
A good response rate to recombinant erythropoietin alone may be expected in selected myelodysplastic patients. A preliminary clinical study 159
Acute myeloid leukemia occurring in a patient with polycythemia vera in treatment with hydroxyurea 154
A rare case of myeloid sarcoma presenting as anal fissure. 151
Adverse outcome in non severe COVID-19: potential diagnostic coagulation tests 148
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 147
Laparoscopic surgery: A randomised controlled trial comparing intraoperative hemodynamic parameters and arterial-blood gas changes at two different pneumoperitoneal pressure values 146
Activation of coagulation anf fibrinolysis in laparoscopic surgery 146
A cause for conversion of laparoscopic splenectomy: splenic candidiasis 146
Abnormal Erytropoietin serum levels in acute leukemia could have a role in the pathophysiology of disease. 144
Activation coagulation and fibrinolysis in laparoscopic surgery 144
Activation of contact phase of blood coagulation can be induced by the sclerosing agent polidocanol: Possible additional mechanism of adverse reaction during sclerotherapy 144
Acute COPD exacerbations cause alteration of the endothelium-coagulative system 139
Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction - Expression of acute phase reaction or index of va- scular endothelium damage? 137
Angiogenesis in essential thrombocythemia: fibroblast growth factor-2 and vascular endothelial growth factor cross-talk 137
Activated factor XII and thrombin activable fibrynolysis inhibitor levels in essential thrombocythemia and polycythemia vera 135
Hemocoagulative Modifications after Laparoscopic Surgery at Different Pneumoperitoneum Pressure Settings. 133
Alterations in ornithine decarboxylase and transglutaminase activities in lymphocytes from untrated patients with chronic lymphocytic leukemia. 133
Abnormalities of haemostatic balance in essential thrombocythemia and polycythemia vera 130
All-trans retinoic (ATRA) induced apoptosis in pe- ripheral freshly isolated chronic myeloid leukemia cells. 129
Surgical drain after open or laparoscopic splenectomy: is it needed or contraindicated? 127
Abnormal production of interleukin (IL)-6 in essential thrombocythemia. 125
Acute lymphoblastic leukemia in elderly. 124
Is it Still Reasonable to Raise Doubts on Laparoscopic Splenectomy? 124
Idiopathic intramural hematoma of the right colon. A case report and review of the literature. 123
Phase II randomized clinical trial comparing ropeginterferon versus phlebotomy in low-risk patients with polycythemia vera. Results of the pre-planned interim analysis. 123
How to prevent intraoperative risks and complications in laparoscopic splenectomy 122
D-dimer in the diagnostic work up of suspected pulmonary embolism: additional clinical value of PTP 121
Preoperative Predictive Factors of Conversions in Laparoscopic Splenectomies 121
Label-Free Enrichment of Circulating Tumor Plasma Cells: Future Potential Applications of Dielectrophoresis in Multiple Myeloma 119
Laparoscopic cholecystectomy in adult patients with sicklecell disease. 119
. Trombospondin plasma levels in beta tha- lassemia:sickle cell disease 119
Alteration of endothelium-coagulative system during COPD exacerbations 119
Hemocoagulative post-operative changes after laparoscopic surgery compared to open surgery: the role of lupus anticoagulant 119
Acquired antithrombin III deficency in sickle cell disease/beta plus thalas- semia. 118
"In vitro" hyperresponsivity of diabetic platelets to "saturated" platelet-activating factor (PAF). 117
Laparoscopic splenectomy: a single center experience 115
Il timing ottimale dell'introito di aspirina nella trombocitemia essenziale 110
Short and Long-Term Risk of Major Cardiovascular Events after Ischemic Stroke or Transient Ischemic Attack in Myeloproliferative Neoplasms 110
Chronic idiopatic trombocytopenic purpura: is there any factor to predict the response to splenectomy? 109
Long-term results after splenectomy in adult idiopathic thrombocitopenic purpura: comparison between open and laparoscopic procedures 106
Laparoscopic Splenectomy Reduces the Need for Platelet Transfusion in Patients With Idiopathic Thrombocytopenic Purpura 106
Cessazione del fumo di sigaretta e riduzione dei livelli plasmatici di fattore di von Willebrand (vWF) 105
betaFibrinigen G-455-A gene polymorphism: is it a factor for aspirin platelet insensitivity in patients with essential thrombocythemia? 104
Study on the Anagrelide on Platelet Factor 4 and Vascular Endothelial Growth Factor Levels in Patients with Essential Thrombocythemia 104
Splanchnic vein thrombosis in JAK2V617F-positive patients with primary myelofibrosis and lower-risk IPSS. 103
Retroperitoneal paraduodenal unicentric Castleman disease: case report and review of the literature 103
Late results after splenectomy in adult idiopathic thrombocytopenic purpura. 102
Laparoscopic splenectomy in patients under the age of eighteen. Experience in 18 cases. 101
Modification of coaugulation and fibrinolysic parameters in laparoscopic cholecystectomy 101
The use of surgical drains in laparoscopic splenectomies. Consideration on a large series of 117 consecutive cases 101
The Antiphospholipid Syndrome 100
In vitro sensitivity of B-CLL cells to Fludarabine and Interferons 100
Sopravvivenza libera da trombosi in 734 pazienti con trombocitemia essenziale (WHO 2016) stratificati secondo lo score "Revised International Prognostic Score for Thrombosis in Essential Thrombocythemia (R-IPSET-Th)". Studio del Regostro ItalianoTrombocitemie (RIT) 99
Evidence for an aincreased fatty acid utilization in platelets in diabetes mellitus: its correlation withn platelet hyperfunction 99
Low dose of ARA-C in chronic myeloid leukemia in blastic transformation 98
I disordini dell'emostasi nelle emopatie maligne. 96
Effects of anagrelide on platelet factor 4 and vascular endothelial growth factor levels in patients with essentiial thrombocythemia: a preliminary report 96
Elevated plasma thrombopoietin levels and thrombosis in essential thrombocythemia: a preliminary report 95
Laparoscopic cholecystectomuy in adult patients with sickle cell disease 95
Aspirin-platelet sensotivity in patients with essentila thtombocythemia: role of betafibrinogen G-455-A gene polymorphism 95
Essential thrombocythemia and fibroblast growth factor-2: role of anagrelide 95
Polidocanol may directly activate the contact phase of blood coagulation during sclerotherapy 94
Alpha interferon as a first line therapy for angioimmunoblastic lympho- adenopathy. Possible value of DR+ cells in monitoring therapeutical re- sponse. 94
All-trans retinoic acid might also induce apoptosis in freshly isolated chro- nic myeloid leukemia cells 93
T-subset abnormalities in Thalassemia intermedia: Possible evidence for a Thymus functional deficiency. 93
PEG Intron treatment in 90 patients with assential thrombocithemia (ET) final report of a phase II study 92
Immunomodulating treatment in patients with aplastic anemia. 91
Factor-VIII-rela- ted antigen and vasculitis. 91
Splenic candidiasis : are perispelnic adhesions contraindications for laparoscopic splenectomy? 91
Il mitoxantrone in polichemioterapia associato allo schema CVP nel trat- tamento dei linfomi non hodgkin. 91
B1-Integrin expression in adult acute lymphoblastic leukemia: Possible relationship with the stem cell antigen CD34 90
VLA-4 and VLA-5 integrin expression in adult acute lymphoblastic leukemia. 90
Unusual onset of severe varicella in adult immunocompromised patients 90
Persistent generalized lymphadenopathy (transfusion-related) in an HIV - seropositive heterosexual man with sckle-cell beta-tha- lassemia. 89
Effects of anagrelide on platelet and fibrinolytic function in patients with essential thrombocythemia 89
Le anemie carenziali. 88
Low-dose cytarabine in myelodisplastic syndromes and acute leukemia: a comment 88
The antiphospholipid syndrome in pregnancy: a review article 88
Platelet factor 4, vascular endothelial growth factor and prothrombin fragment 1+2 levels in essential thrombocythemia treated with anagrelide 88
B- chronic lymphocytic lekemia cells forming rosettes with sheep erythrocytes 88
MECCANISMO DI ATTIVAZIONE PIASTRINICA NELLA TROMBOCITEMIA ESSENZIALE: RUOLO DEGLI ANTICORPI ANTI CELLULA ENDOTELIALE (AACE) 87
Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis 87
Laparoscopic splenectomy reduces the need of platelet transfusion in patients operated on for idiopathic thrombocytopenic purpura 87
Cutaneous vasculitis in non Hodgkin's Lymphoma. 86
Thymostimulin in aplastic anaemia. 86
Role of FcR+ T-cells on the mechanism of the depressed polyclonal immunoglobulin synthesis in human mye- loma. 86
Portal vein thrombosis after laparoscopic splenectomy: report on personal experience 86
Cardiovascular events and intensity of treatment in Polycythemia vera 86
Interleukin-8 levels in patients with essential thrombocythemia. 85
Postsplenectomy Portal Vein Thrombosis: Personal Experience and Review of the Literature 85
COVID-19 in Essential Thrombocythemia: Coagulopathy and Thrombosis 85
Prothrombin concentration in patients heterozygous for the G20210 and Arg506Gln mutations 84
Totale 11.838
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.598
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202161 0 0 0 0 0 0 0 0 0 0 0 61
2021/20222.657 346 387 21 30 429 5 394 92 282 5 63 603
2022/20233.474 365 93 28 229 348 652 4 576 971 29 115 64
2023/20241.666 81 110 73 86 65 160 160 355 17 40 230 289
2024/20255.265 38 716 369 170 1.183 404 110 201 517 689 313 555
2025/202612.558 704 595 2.641 779 2.097 2.043 1.838 295 661 553 257 95
Totale 30.179